Backed by Peter Thiel and OpenAI, Toronto startup Biossil aims to give failed drugs new life with AI

That’s the idea behind Biossil Inc., founded in 2023 by Anthony Mouchantaf, a lawyer-turned tech entrepreneur who previously ...
pharmaphorum

J&J bets on Isomorphic for AI-powered drug hunt

Alphabet-backed start-up Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine. Johnson & Johnson's Janssen Biotech unit is the ...
pharmaphorum

Alphabet's DeepMind forms AI drug discovery unit Isomorphic Labs

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...